Invenex Search is currently retained with a precision oncology biotech based in France who are pioneering a unique survivor-driven approach to cancer biology. Backed by top-tier investors, they're building a bold pipeline powered by translational data science and deep biological insights. The company is looking for a Chief Development Officer to lead their drug development strategy from early clinical design.
Responsibilities:
Lead clinical development strategy across all programs (early and late-stage).
Drive IND/CTA submissions, clinical trial design, and regulatory interactions.
Oversee cross-functional development teams (Clinical Ops, Regulatory, Medical).
Integrate translational science, biomarker strategy, and patient data into program design.
Build external partnerships with CROs, academic collaborators, and pharma.
Represent the company with regulators, board members, and investors.
Experience Required:
MD, PhD, or equivalent in Oncology, Immunology, or Molecular Biology.
15+ years in biotech or biopharma with hands-on oncology drug development leadership.
Deep understanding of translational and clinical science integration.
Track record in successfully advancing programs through key development milestones.
Strong leadership in a startup or early-growth company environment preferred.
Excellent interpersonal and strategic communication skills.